Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nuvation Bio Inc. Director's Dealing 2024

Sep 5, 2024

32154_dirs_2024-09-05_7f10797c-0465-4410-a070-9e4017c5ec19.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2024-09-03

Reporting Person: VERNON W ANTHONY (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-09-03 Stock Option (Right to Buy) $2.98 A 200801 Acquired 2034-09-02 Class A Common Stock (200801) Direct

Footnotes

F1: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (September 3, 2024); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.